Rasio Therapeutics, Inc.

Rasio Therapeutics is a biopharmaceutical company that develops novel medicines using computer-aided drug design technology. Its core strategy is to keep overhead and infrastructure costs low while accelerating the ability to trigger liquidity events. With this model, they are running multiple drug discovery and development programs in parallel. It aims to address unmet patient needs through modeling of novel/deep cell-binding regions. Rasio designs molecules to fit those regions and enhance treatment for cancer and other diseases. The company was founded in 2019 and is based in Baltimore, Maryland.

show less